4/8
08:02 am
ocgn
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
High
Report
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
3/26
06:08 pm
ocgn
LUXTURNA Continues to Lead in Retinal Gene Therapy with Increased Market Penetration | DelveInsight [Yahoo! Finance]
Low
Report
LUXTURNA Continues to Lead in Retinal Gene Therapy with Increased Market Penetration | DelveInsight [Yahoo! Finance]
3/18
08:02 am
ocgn
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
Medium
Report
Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema
3/6
08:33 am
ocgn
Ocugen, Inc. (NASDAQ: OCGN) had its price target raised by analysts at Chardan Capital from $6.00 to $7.00. They now have a "buy" rating on the stock.
Medium
Report
Ocugen, Inc. (NASDAQ: OCGN) had its price target raised by analysts at Chardan Capital from $6.00 to $7.00. They now have a "buy" rating on the stock.
3/6
08:12 am
ocgn
Ocugen, Inc. (NASDAQ: OCGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Medium
Report
Ocugen, Inc. (NASDAQ: OCGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
3/6
02:16 am
ocgn
Ocugen Inc (OCGN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs [Yahoo! Finance]
Medium
Report
Ocugen Inc (OCGN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs [Yahoo! Finance]
3/5
01:27 pm
ocgn
Ocugen (OCGN) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Ocugen (OCGN) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
3/5
11:01 am
ocgn
https://seekingalpha.com/article/4764889-ocugen-inc-ocgn-q4-2024-earnings-call-transcript [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4764889-ocugen-inc-ocgn-q4-2024-earnings-call-transcript [Seeking Alpha]
3/5/2025
07:02 am
OCGN
ocugen, inc.
IN-LINE
Report
-4.4%
ocugen, inc.
3/5/2025
07:02 am
OCGN
ocugen, inc.
IN-LINE
Report
-4.4%
ocugen, inc.
3/5/2025
07:02 am
OCGN
ocugen, inc.
IN-LINE
Report
-5.7%
ocugen, inc.
3/5/2025
07:02 am
OCGN
ocugen, inc.
IN-LINE
Report
-6.0%
ocugen, inc.
4/4
09:23 am
ocgn
Form 8-K Ocugen, Inc. For: Apr 04
Medium
Report
Form 8-K Ocugen, Inc. For: Apr 04
3/5
04:31 pm
ocgn
Form S-8 Ocugen, Inc.
Medium
Report
Form S-8 Ocugen, Inc.
3/5
09:43 am
ocgn
Form 10-K Ocugen, Inc. For: Dec 31
Medium
Report
Form 10-K Ocugen, Inc. For: Dec 31
3/5
07:00 am
ocgn
Form 8-K Ocugen, Inc. For: Mar 05
Medium
Report
Form 8-K Ocugen, Inc. For: Mar 05
3/3
08:43 am
ocgn
Form 8-K Ocugen, Inc. For: Mar 03
High
Report
Form 8-K Ocugen, Inc. For: Mar 03
2/14
06:05 am
ocgn
Form EFFECT Ocugen, Inc.
Low
Report
Form EFFECT Ocugen, Inc.
2/12
08:39 am
ocgn
Form 8-K Ocugen, Inc. For: Feb 12
Medium
Report
Form 8-K Ocugen, Inc. For: Feb 12
2/7
04:06 pm
ocgn
Form 8-K/A Ocugen, Inc. For: Nov 06
Medium
Report
Form 8-K/A Ocugen, Inc. For: Nov 06
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register